The Maryland Jockey Club has enacted a house rule for the Laurel Park meet that requires trainers of claimed horses to report joint injections administered in the previous 30 days.
The Indiana Horse Racing Commission believes Truesdail Laboratories missed seven positives, including a Class I drug, in just 26 days of handling drug tests for the state.
Horsemen's representatives told the Ohio Horse Racing Commission March 30 that equine medication rules, which the commission is reviewing, should be breed-specific in nature.
As part of its extensive investigation into Steve Asmussen stable following allegations of horse mistreatment from an animal rights group, the KHRC compiled safety numbers in which the trainer fared well
Rules were designed to protect the integrity of pari-mutuel wagering and horses' health.
New York regulators are ready to consider final revisions to rules specifying allowable testing threshold levels for two dozen medications used to treat Thoroughbreds in advance of races.
The New York Racing Association Oct. 17 expressed its full support of the New York State Gaming Commission's proposed rules on threshold limits for therapeutic medications on race day.
As the North American Thoroughbred industry continues its quest to lower the catastrophic breakdown rate, it is actively pushing the need to identify at-risk racehorses, even if the effort makes stakeholders uncomfortable.
The Kentucky Horse Racing Commission is collecting information on corticosteroid elimination times following specific uses of the medications provided by participating racetrack veterinarians.
A horsemen's meeting on upcoming equine medication changes in Kentucky revealed some interesting information: The four months of racing at Turfway Park are the "cleanest" in the state according to drug-testing results.
Kentucky horsemen March 14 were given an overview of impending equine medication changes and also provided with a few tips to avoid headaches when the new regulations take effect later in the spring.
Initial results of a study conducted by the University of Kentucky Gluck Equine Research Center suggest accepted dosage levels for several corticosteroids commonly used in racing should be examined.
The Kentucky Horse Racing Commission on Dec. 11 approved changes to its withdrawal time guidelines for all racing breeds in line with the national uniform medication rules.
Amid another call for separate medication rules for Thoroughbreds and Standardbreds, the Ohio State Racing Commission has indicated it's not prepared to adopt a uniform national drug policy.
The Kentucky Equine Drug Research Council, on a 4-2 vote Dec. 3, recommended the Kentucky Horse Racing Commission adopt the national uniform medication rules for Thoroughbred racing.
A pair of position papers released by the Racing Medication and Testing Consortium find no physiologic difference in various racing breeds to justify changes to its regulatory thresholds for clenbuterol and corticosteroids.
New York regulators Sept. 9 re-issued an expired rule requiring the previous trainer of a claimed horse to provide the new owner with all records regarding corticosteroid joint injections within 48 hours of the race.
The Racing Medication and Testing Consortium has approved minimum withdrawal time recommendations for corticosteroids based on recently completed work partially funded by RMTC.
With regulators and industry groups leading the charge, many horse racing stakeholders believe sweeping medication reform could become a reality in early 2013.
The use of corticosteroids in racehorses has created controversy, but the medications are beneficial when used appropriately. That was Dr. Wayne McIlwraith's message during the Welfare and Safety of the Racehorse Summit IV.
Prodded by a rash of equine deaths at Aqueduct Racetrack last winter, the New York State Racing and Wagering Board Oct. 11 imposed what officials promised will be the first round of rules intended to make for safer racing.
New York racing officials are set to begin implementing new rules based on recommendations by a recent industry task force report to increase safety conditions for horses and jockeys.
Corticosteroid injections are overused on racehorses but don't contribute to catastrophic breakdowns, a medication consultant said during a June 27 continuing education program for licensed Thoroughbred horsemen in Indiana.
Diagnosing and treating upper and lower respiratory issues and the use of corticosteroids in racehorses will be discussed as part of a continuing education seminar for trainers June 27 at Indiana Downs.
The New York Thoroughbred Horsemen's Association April 13 announced a plan to reform medication policies in Thoroughbred racing that it believes addresses many of the issues that have brought criticism to the sport.
The Kentucky Drug Equine Research Council, citing a need to explore use of corticosteroids in racehorses, agreed Feb. 9 to take bids for research into one of the drugs in the research planning phase.
The England-based auction firm will introduce a program for yearlings at this fall's sales.
- By Tom LaMarra
As it prepares for its annual meeting April 12-15, the Association of Racing Commissioners International has released a three-year strategic plan focusing on reforms in regulation, medication, and wagering security.
The Pennsylvania Horse Racing Commission has adopted a policy whereby administration of corticosteroids in horses must be stopped seven days prior race day.
- By Tom LaMarra
Though most racing jurisdictions in North America have greatly curtailed the use of race-day medication, two drugs commonly used in racehorses are getting a hard look from industry officials.
- By Tom LaMarra
The Racing Medication and Testing Consortium recently prepared a list of 2009-10 goals, one of which is tackling use of corticosteroids in racehorses.
- By Tom LaMarra
A discussion into the use and effectiveness of corticosteroids--therapeutic anti-inflammatory drugs--was full of twists and turns July 21 but inevitably settled on the areas of threshold levels, withdrawal times, and finally the question of whether a stringent policy for race-day medication is practical.
Corticosteroids, which serve as anti-inflammatory agents, will be the focus of a panel discussion July 21 during the National Horsemen's Benevolent and Protective Association summer convention in Toronto, Canada.
- By Tom LaMarra
In the second round of "super tests" performed under the guidance of the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force, there were no new positives for Class 1, 2, and 3 medications, according to a final report recently released. There were, however, 454 confirmations for therapeutic drugs.
Most Popular Stories
- Curalina Opens Year with La Troienne Win
- Derby Observations, Strategy, and Wagers
- Routine, Quiet Oaks Morning on Backside
- Nyquist Draws Post 13, is 3-1 Derby Favorite
- Field of 22 Set for 142nd Kentucky Derby
- NBC Offers Virtual Kentucky Derby Experience
- Derby by the Speed Numbers
- Unlocking Winners Kentucky Derby 142 Analysis
- Force the Pass Heads Fort Marcy
- Team Optimistic, Nyquist 'Full of Energy'